Category Archives: Biotech Marketing
On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.
Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.
Healthcare reform is changing the way that healthcare marketers think about everything from clinical trials to product launches. New payment models, new delivery models, and HEOR mandates are all creating major changes in marketing focus for medical device, biotech, pharmaceutical, and medical diagnostics companies.
At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.
On July 1st, 2014 we officially launched the Minneapolis / St. Paul office of DevicePharm. One of the first decisions we made after opening our doors was to participate in a sponsorship of LifeScience Alley. LifeScience Alley is a nonprofit trade association that supports Minnesota’s healthcare industry. The organization boasts more than 1400 members across the medical device, biotech and pharmaceutical industries. They primarily assist the local life science community with legislative issues, education and investment in the state.
For a biotech company seeking to successfully launch and market a new product, especially for a company that has focused all its hopes and resources on a single new product, the stakes are very high indeed.